Clinical Research Facility

Fremont, Nebraska 68025

Use our guide to learn which trials are right for you!

We've found
9 trials
at this facility
Moderate to Very Severe Chronic Obstructive Pulmonary Disease Clinical Trial
Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History
Status: Enrolling, Phase III
Updated: 3/8/2016
mi
from
Fremont, NE
Click here to add this to my saved trials
Irritable Bowel Syndrome With Diarrhea Clinical Trial
Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
Status: Enrolling, Phase III
Updated: 12/9/2013
mi
from
Fremont, NE
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients.
Status: Enrolling, Phase IV
Updated: 3/18/2016
mi
from
Fremont, NE
Click here to add this to my saved trials
Endocrinology Clinical Trial
A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
Status: Enrolling, Phase IV
Updated: 5/4/2015
mi
from
Fremont, NE
Click here to add this to my saved trials
Endocrinology, Nephrology / Urology Clinical Trial
Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy
Status: Enrolling, Phase III
Updated: 3/18/2016
mi
from
Fremont, NE
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)
Status: Enrolling, Phase IV
Updated: 4/1/2016
mi
from
Fremont, NE
Click here to add this to my saved trials
Endocrinology Clinical Trial
Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
Status: Enrolling, Phase III
Updated: 3/7/2016
mi
from
Fremont, NE
Click here to add this to my saved trials
Rhinoconjunctivitis Clinical Trial
Phase III Cat-PAD Study
Status: Enrolling, Phase III
Updated: 3/22/2016
mi
from
Fremont, NE
Click here to add this to my saved trials
Cardiovascular Disease, Diabetes Mellitus Type 2 Clinical Trial
A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose Abnormalities
Status: Enrolling, Phase III
Updated: 4/2/2016
mi
from
Fremont, NE
Click here to add this to my saved trials